ProfileGDS4718 / 209162_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 51% 66% 52% 57% 82% 80% 65% 62% 62% 66% 62% 76% 82% 77% 71% 71% 73% 79% 58% 57% 64% 67% 68% 59% 80% 63% 65% 63% 71% 75% 78% 50% 60% 69% 74% 75% 65% 62% 70% 65% 76% 70% 72% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4591465
GSM549102patient 115, normal, homogenized [OPG study]5.5650651
GSM549104patient 119, normal, homogenized [OPG study]6.6267766
GSM549108patient 138, normal, homogenized [OPG study]5.6872552
GSM549119patient 077, normal, homogenized [OPG study]5.9206657
GSM549133patient 032, cancer, homogenized [OPG study]8.1916682
GSM549139patient 042, cancer, homogenized [OPG study]7.9151580
GSM549099patient 107, normal, homogenized [OPG study]6.4278865
GSM549109patient 139, normal, homogenized [OPG study]6.2991662
GSM549110patient 046, normal, homogenized [OPG study]6.2829762
GSM549114patient 063, normal, homogenized [OPG study]6.5465366
GSM549122patient 082, normal, homogenized [OPG study]6.2953462
GSM549134patient 033, cancer, homogenized [OPG study]7.4208976
GSM549136patient 036, cancer, homogenized [OPG study]8.202982
GSM549140patient 044, cancer, homogenized [OPG study]7.6205177
GSM549111patient 047, normal, homogenized [OPG study]7.0048271
GSM549113patient 057, normal, homogenized [OPG study]6.9529371
GSM549132patient 031, cancer, homogenized [OPG study]7.2057573
GSM549137patient 038, cancer, homogenized [OPG study]7.7670279
GSM549142patient 047, cancer, homogenized [OPG study]6.1008758
GSM549100patient 110, normal, homogenized [OPG study]5.9493157
GSM549107patient 135, normal, homogenized [OPG study]6.4101464
GSM549115patient 068, normal, homogenized [OPG study]6.6567367
GSM549116patient 072, normal, homogenized [OPG study]6.7320868
GSM549120patient 078, normal, homogenized [OPG study]6.0448159
GSM549131patient 030, cancer, homogenized [OPG study]7.9555980
GSM549118patient 074, normal, homogenized [OPG study]6.3672663
GSM549129patient 027, cancer, homogenized [OPG study]6.5059665
GSM549123patient 088, normal, homogenized [OPG study]6.3449563
GSM549124patient 006, cancer, homogenized [OPG study]6.9270371
GSM549126patient 015, cancer, homogenized [OPG study]7.2898675
GSM549128patient 025, cancer, homogenized [OPG study]7.7038678
GSM549103patient 117, normal, homogenized [OPG study]5.5696150
GSM549117patient 073, normal, homogenized [OPG study]6.0900960
GSM549138patient 041, cancer, homogenized [OPG study]6.8488669
GSM549141patient 045, cancer, homogenized [OPG study]7.3330174
GSM549130patient 028, cancer, homogenized [OPG study]7.2758675
GSM549101patient 111, normal, homogenized [OPG study]6.4687365
GSM549105patient 128, normal, homogenized [OPG study]6.2583162
GSM549106patient 134, normal, homogenized [OPG study]6.9885570
GSM549112patient 048, normal, homogenized [OPG study]6.4743165
GSM549125patient 011, cancer, homogenized [OPG study]7.3554476
GSM549127patient 024, cancer, homogenized [OPG study]6.9625770
GSM549135patient 035, cancer, homogenized [OPG study]7.1618672